BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12964647)

  • 1. Role of kidney in hypertension.
    Tripathi S; Tripathi K
    J Indian Med Assoc; 2003 Apr; 101(4):260-2, 264-5. PubMed ID: 12964647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1985 Nov; 3(2):S81-7. PubMed ID: 3003304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Weir MR
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibition in hypertension.
    Gradman AH; Kad R
    J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system, the kidney, and hypertension.
    Rosenfeld JB; Zabludowski J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S22-6. PubMed ID: 2474096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of renin: an updated review of the development of renin inhibitors.
    Li YC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
    Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
    Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.